June Seymour
Chief Accounting OfficerMs. June Seymour is Chief Accounting Officer of Cartesian Therapeutics, Inc. from October 27, 2025. Ms. Seymour has financial leadership experience in the life sciences sector. She most recently served as Senior Vice President, Finance and Accounting at DNAnexus, Inc. since May 2024 and prior to that was Vice President, Finance at Neogene Therapeutics Inc., where she led her team through the company's sale to AstraZeneca and post-acquisition integration between January 2022 and May 2024. From 2019 to 2022, Ms. Seymour held roles of increasing responsibility at Autolus Ltd., including Executive Director, Finance and Senior Director, Financial Reporting. Earlier in her career, from 2003 to 2019, she was a Senior Manager at Ernst & Young LLP in London, specializing in U.S. transactions involving European life sciences companies. Ms. Seymour holds a Bachelor of Science in Business Administration and Accountancy from Methodist University and is a Certified Public Accountant.
公司职务
- 公司名称Cartesian Therapeutics, Inc.股票代码RNAC职务Chief Accounting Officer共事同僚
- CBCarsten BrunnPresident, CEO & Chairman of the Board
- BTBlaine T. DavisChief Financial Officer
- EEEmily EnglishChief Operating Officer
- CGChar GrossFractional Chief People Officer
- TCTimothy C. BarabeIndependent Director
- PJPatrick J. ZennerLead Independent Director
- KMKemal MalikIndependent Director
- MSMichael Scott SingerIndependent Director
